Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 08, 2007 | Director | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 713 | |
| Feb 01, 2006 | Vice-President - Research | Form 4 | Open market or private sale of non-derivative or derivative security | 4,000 | $27.01 | 654 | |
| Jan 06, 2006 | Vice-President - Research | Form 4 | Open market or private sale of non-derivative or derivative security | 5,000 | $26.75 | 654 | |
| Jan 03, 2006 | Vice-President - Research | Form 4 | Open market or private sale of non-derivative or derivative security | 2,000 | $25.36 | 654 | |
| Jan 03, 2006 | Vice-President - Research | Form 4 | Open market or private sale of non-derivative or derivative security | 3,000 | $25.11 | 654 | |
| Dec 15, 2005 | Vice-President - Research | Form 4 | Open market or private sale of non-derivative or derivative security | 5,000 | $26.75 | 654 | |
| Dec 14, 2005 | Vice-President - Research | Form 4 | Open market or private sale of non-derivative or derivative security | 2,000 | $25.25 | 654 | |
| Dec 06, 2005 | Vice-President - Research | Form 4 | Open market or private sale of non-derivative or derivative security | 2,000 | $23.00 | 654 | |
| Dec 01, 2005 | Vice-President - Research | Form 4 | Open market or private sale of non-derivative or derivative security | 1,000 | $21.50 | 654 | |
| Jun 02, 2017 | SVP, GM - Oncology | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 647 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.